Premium
Regulation of VEGF induced angiogenesis by β3 integrin through recruitment of VEGFR‐2 associated protein tyrosine phosphatase
Author(s) -
Mahabaleshwar Ganapati H,
Byzova Tatiana
Publication year - 2008
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.22.1_supplement.746.8
Subject(s) - angiogenesis , microbiology and biotechnology , protein tyrosine phosphatase , tyrosine phosphorylation , integrin , phosphorylation , receptor tyrosine kinase , vascular endothelial growth factor , tyrosine , biology , sh2 domain , tyrosine kinase , endothelial stem cell , vascular endothelial growth factor a , chemistry , signal transduction , cancer research , biochemistry , receptor , vegf receptors , in vitro
Angiogenesis, the formation of new blood vessels from preexisting vasculature, occurs in a variety of physiological and pathological conditions. The process of angiogenesis is known to be regulated by vascular endothelial growth factor (VEGF) and its receptors (VEGFR‐2) in coordination with extracellular matrix interacting molecules such as integrins. Integrins have been reported to exhibit extracellular matrix dependent regulation of several tyrosine kinases on endothelial cell surfaces. In this study we have revealed the role of β 3 integrin cytoplasmic tyrosine motifs in the regulation of protein tyrosine phosphatase (PTPs), associated with VEGFR‐2, in a tyrosine phosphorylation‐dependent manner. SHP‐2 association with VEGFR‐2 regulates the extent of basal and growth factor‐induced VEGFR‐2 phosphorylation in endothelial cells. Additionally, phosphorylated β 3 integrin cytoplasmic tyrosine motifs provide binding sites for SHP‐2 and protect VEGFR‐2 from dephosphorylation. Moreover, DiYF endothelial cells, in which β 3 integrin cytoplasmic tyrosine motifs are mutated to phenylalanine, exhibit deficient SHP‐2 binding to β 3 integrin and VEGF stimulation, also display a modest decrease in SHP‐2 dissociation from VEGFR‐2 and decreased pathological angiogenesis in vivo . Further, we have also demonstrated that SHP‐2 binds to phosphorylated tyrosine residue 773 of the β 3 cytoplasmic domain, and that β 3 integrin cytoplasmic‐derived cell permeable prephosphorylated peptide 773Yp reduced VEGF‐induced VEGFR‐2 tyrosine phosphorylation and down stream signaling, endothelial cell migration, tube formation, ex vivo and in vivo angiogenesis. We have for the first time demonstrated this novel mechanism which regulates processes of VEGFR‐2 activation and pathological angiogenesis.